Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Dianne Madelyn Finkelstein, Ph.D.

Profile Picture

The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. P50CA165962 (BATCHELOR, TRACY T) Sep 19, 2013 - Aug 31, 2024
    SPORE: Targeted Therapies for Glioma
    Role: Co-Principal Investigator
  2. R01CA160233 (FINKELSTEIN, DIANNE M) Sep 5, 2012 - Jun 30, 2019
    Rare Cancer Genetics Registry
    Role: Principal Investigator
  3. R03CA167570 (FINKELSTEIN, DIANNE M) Apr 4, 2012 - Mar 31, 2016
    Analysis of Risks and Outcomes for Rare Cancers
    Role: Principal Investigator
  4. RC1CA144706 (FINKELSTEIN, DIANNE M) Sep 30, 2009 - Aug 31, 2012
    Rare Cancer Genetics Registry
    Role: Principal Investigator
  5. R03CA125766 (FINKELSTEIN, DIANNE M) Sep 1, 2007 - Aug 31, 2010
    Methods for Statistical Analysis of Cancer Genetic Network Studies
    Role: Principal Investigator

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Schoenfeld DA, Ramchandani R, Finkelstein DM. Designing a longitudinal clinical trial based on a composite endpoint: Sample size, monitoring, and adaptation. Stat Med. 2022 Jul 11. PMID: 35818331.
    Citations:    Fields:    
  2. North CM, Barczak A, Goldstein RH, Healy BC, Finkelstein DM, Ding DD, Kim A, Boucau J, Shaw B, Gilbert RF, Vyas T, Reynolds Z, Siddle KJ, MacInnis BL, Regan J, Flynn JP, Choudhary MC, Vyas JM, Laskowski K, Dighe AS, Lemieux JE, Li JZ, Baden LR, Siedner MJ, Woolley AE, Sacks CA. Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination. Clin Infect Dis. 2022 04 09; 74(7):1275-1278. PMID: 34363462; PMCID: PMC8436402.
    Citations: 8     Fields:    Translation:HumansCellsPHPublic Health
  3. Coleman R, Finkelstein DM, Barrios C, Martin M, Iwata H, Hegg R, Glaspy J, Periañez AM, Tonkin K, Deleu I, Sohn J, Crown J, Delaloge S, Dai T, Zhou Y, Jandial D, Chan A. Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2020 01; 21(1):60-72. PMID: 31806543.
    Citations: 49     Fields:    Translation:HumansCTClinical Trials
  4. Schoenfeld DA, Finkelstein DM, Macklin E, Zach N, Ennist DL, Taylor AA, Atassi N. Design and analysis of a clinical trial using previous trials as historical control. Clin Trials. 2019 10; 16(5):531-538. PMID: 31256630.
    Citations: 1     Fields:    Translation:Humans
  5. Finkelstein DM, Horick NK, Ramchandani R, Boyd KL, Rana HQ, Bychkovsky BL. Are rare cancer survivors at elevated risk of subsequent new cancers? BMC Cancer. 2019 Feb 21; 19(1):166. PMID: 30791872.
    Citations:    Fields:    Translation:Humans
  6. Ramchandani R, Finkelstein DM, Schoenfeld DA. Estimation for an accelerated failure time model with intermediate states as auxiliary information. Lifetime Data Anal. 2020 01; 26(1):1-20. PMID: 30386969.
    Citations:    Fields:    Translation:Humans
  7. Horick NK, Muzikansky A, Gutierrez HL, Boyd KL, Finkelstein DM. Physical symptoms in long-term survivors of rare cancer. J Cancer Surviv. 2018 12; 12(6):835-842. PMID: 30315392.
    Citations: 1     Fields:    Translation:Humans
  8. Finkelstein DM, Schoenfeld DA. Graphing the Win Ratio and its components over time. Stat Med. 2019 01 15; 38(1):53-61. PMID: 30206956.
    Citations: 3     Fields:    Translation:Humans
  9. Debiasi M, Polanczyk CA, Ziegelmann P, Barrios C, Cao H, Dignam JJ, Goss P, Bychkovsky B, Finkelstein DM, Guindalini RS, Filho P, Albuquerque C, Reinert T, de Azambuja E, Olopade O. Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis. Front Oncol. 2018; 8:156. PMID: 29872641; PMCID: PMC5972314.
    Citations: 13     
  10. Hsu JJ, Finkelstein DM, Schoenfeld DA. Informatively clustering longitudinal microarrays using binary or survival outcome data. Commun Stat Case Stud Data Anal Appl. 2018; 4(1):18-27. PMID: 30854419; PMCID: PMC6405222.
  11. Matissek KJ, Onozato ML, Sun S, Zheng Z, Schultz A, Lee J, Patel K, Jerevall PL, Saladi SV, Macleay A, Tavallai M, Badovinac-Crnjevic T, Barrios C, Bese N, Chan A, Chavarri-Guerra Y, Debiasi M, Demirdögen E, Egeli Ü, Gökgöz S, Gomez H, Liedke P, Tasdelen I, Tolunay S, Werutsky G, St Louis J, Horick N, Finkelstein DM, Le LP, Bardia A, Goss PE, Sgroi DC, Iafrate AJ, Ellisen LW. Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer. Cancer Discov. 2018 03; 8(3):336-353. PMID: 29242214.
    Citations: 17     Fields:    Translation:HumansAnimalsCells
  12. Mruzek DW, McAleavey S, Loring WA, Butter E, Smith T, McDonnell E, Levato L, Aponte C, Travis RP, Aiello RE, Taylor CM, Wilkins JW, Corbett-Dick P, Finkelstein DM, York AM, Zanibbi K. A pilot investigation of an iOS-based app for toilet training children with autism spectrum disorder. Autism. 2019 02; 23(2):359-370. PMID: 29212345.
    Citations:    Fields:    Translation:Humans
  13. Frenk NE, Spring L, Muzikansky A, Vadvala HV, Gurski JM, Henderson LE, Mino-Kenudson M, Ly A, Bardia A, Finkelstein D, Engelman J, Mueller PR, Juric D, Weissleder R. High-Content Biopsies Facilitate Molecular Analyses and Do Not Increase Complication Rates in Patients With Advanced Solid Tumors. JCO Precis Oncol. 2017 Nov; 1:1-9. PMID: 35172508.
    Citations: 2     Fields:    
  14. Reyes S, Horick N, Clark J, Murphy J, Blaszkowsky L, Allen J, Ryan DP, Hong T, Wo J, Nipp R, Parikh A, Faris J, Kwak E, Galway A, Knowles M, Oklu R, John IA, Lennerz J, Finkelstein D, Borger D, Zhu A, Goyal L. Frequency and impact of tumor genotyping in clinical practice of patients with advanced biliary tract cancers (ABTCs). Ann Oncol. 2017 Jun; 28 Suppl 3:iii145-iii146. PMID: 32135779.
  15. Skates SJ, Greene MH, Buys SS, Mai PL, Brown P, Piedmonte M, Rodriguez G, Schorge JO, Sherman M, Daly MB, Rutherford T, Brewster WR, O'Malley DM, Partridge E, Boggess J, Drescher CW, Isaacs C, Berchuck A, Domchek S, Davidson SA, Edwards R, Elg SA, Wakeley K, Phillips KA, Armstrong D, Horowitz I, Fabian CJ, Walker J, Sluss PM, Welch W, Minasian L, Horick NK, Kasten CH, Nayfield S, Alberts D, Finkelstein DM, Lu KH. Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials. Clin Cancer Res. 2017 Jul 15; 23(14):3628-3637. PMID: 28143870; PMCID: PMC5726402.
    Citations: 32     Fields:    Translation:Humans
  16. Chavarri-Guerra Y, St Louis J, Bukowski A, Soto-Perez-de-Celis E, Liedke PER, Symecko H, Moy B, Higgins M, Finkelstein DM, Goss PE. Real world patterns of care in HER2-overexpressing breast cancer: Results of a survey of TEACH clinical trial investigators in 2011. Breast. 2017 Feb; 31:197-201. PMID: 27894048.
    Citations: 3     Fields:    Translation:Humans
  17. Horick NK, Manful A, Lowery J, Domchek S, Moorman P, Griffin C, Visvanathan K, Isaacs C, Kinney AY, Finkelstein DM. Physical and psychological health in rare cancer survivors. J Cancer Surviv. 2017 02; 11(1):158-165. PMID: 27761785.
    Citations: 5     Fields:    Translation:Humans
  18. Schoenfeld DA, Finkelstein DM. Assessing survival benefit when treatment delays disease progression. Clin Trials. 2016 06; 13(3):352-7. PMID: 26908538.
    Citations: 2     Fields:    Translation:Humans
  19. Patel SG, Ahnen DJ, Kinney AY, Horick N, Finkelstein DM, Hill DA, Lindor NM, MaCrae F, Lowery JT. Knowledge and Uptake of Genetic Counseling and Colonoscopic Screening Among Individuals at Increased Risk for Lynch Syndrome and their Endoscopists from the Family Health Promotion Project. Am J Gastroenterol. 2016 Feb; 111(2):285-93. PMID: 26856748; PMCID: PMC5193129.
    Citations: 12     Fields:    Translation:Humans
  20. Strasser-Weippl K, Horick N, Smith IE, O'Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE. Identification of early breast cancer patient cohorts who may benefit from lapatinib therapy. Eur J Cancer. 2016 Mar; 56:85-92. PMID: 26829011.
    Citations: 3     Fields:    Translation:HumansCells
  21. Ramchandani R, Schoenfeld DA, Finkelstein DM. Global rank tests for multiple, possibly censored, outcomes. Biometrics. 2016 09; 72(3):926-35. PMID: 26812695.
    Citations: 9     Fields:    Translation:Humans
  22. Hsu JJ, Finkelstein DM, Schoenfeld DA. Outcome-Driven Cluster Analysis with Application to Microarray Data. PLoS One. 2015; 10(11):e0141874. PMID: 26562156.
    Citations: 1     Fields:    Translation:Humans
  23. Mazumdar M, Messinger S, Finkelstein DM, Goldberg JD, Lindsell CJ, Morton SC, Pollock BH, Rahbar MH, Welty LJ, Parker RA. Evaluating Academic Scientists Collaborating in Team-Based Research: A Proposed Framework. Acad Med. 2015 Oct; 90(10):1302-8. PMID: 25993282; PMCID: PMC4653084.
    Citations: 15     Fields:    Translation:Humans
  24. Strasser-Weippl K, Horick N, Smith IE, O'Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE. Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy. Breast Cancer Res. 2015 Apr 16; 17:56. PMID: 25888246; PMCID: PMC4423419.
    Citations: 16     Fields:    Translation:Humans
  25. Isakoff SJ, Mayer EL, He L, Traina TA, Carey LA, Krag KJ, Rugo HS, Liu MC, Stearns V, Come SE, Timms KM, Hartman AR, Borger DR, Finkelstein DM, Garber JE, Ryan PD, Winer EP, Goss PE, Ellisen LW. TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer. J Clin Oncol. 2015 Jun 10; 33(17):1902-9. PMID: 25847936; PMCID: PMC4451173.
    Citations: 147     Fields:    Translation:HumansCTClinical Trials
  26. Boyle FM, Smith IE, O'Shaughnessy J, Ejlertsen B, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Amonkar M, Huang Y, Rappold E, Williams LS, Wang-Silvanto J, Kaneko T, Finkelstein DM, Goss PE. Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human Epidermal Growth Factor Receptor (HER2) overexpressing breast cancer. Eur J Cancer. 2015 Apr; 51(6):685-96. PMID: 25752740.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  27. Ager EI, Kozin SV, Kirkpatrick ND, Seano G, Kodack DP, Askoxylakis V, Huang Y, Goel S, Snuderl M, Muzikansky A, Finkelstein DM, Dransfield DT, Devy L, Boucher Y, Fukumura D, Jain RK. Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy. J Natl Cancer Inst. 2015 Apr; 107(4). PMID: 25710962; PMCID: PMC4402365.
    Citations: 61     Fields:    Translation:HumansAnimalsCells
  28. Ramchandani R, Finkelstein DM, Schoenfeld DA. A model-informed rank test for right-censored data with intermediate states. Stat Med. 2015 Apr 30; 34(9):1454-66. PMID: 25582933.
    Citations: 1     Fields:    Translation:Humans
  29. Strasser-Weippl K, Ramchandani R, Fan L, Li J, Hurlbert M, Finkelstein D, Shao ZM, Goss PE. Pregnancy-associated breast cancer in women from Shanghai: risk and prognosis. Breast Cancer Res Treat. 2015 Jan; 149(1):255-61. PMID: 25504083; PMCID: PMC6613825.
    Citations: 10     Fields:    Translation:Humans
  30. O'Donnell E, Mahindra A, Yee AJ, Nardi V, Birrer N, Horick N, Borger D, Finkelstein D, Iafrate JA, Raje N. Clinical Grade "SNaPshot" Genetic Mutation Profiling in Multiple Myeloma. EBioMedicine. 2015 Jan; 2(1):71-3. PMID: 26137536.
    Citations: 7     Fields:    Translation:HumansCells
  31. Chavarri-Guerra Y, Higgins MJ, Szymonifka J, Cigler T, Liedke P, Partridge A, Ligibel J, Come SE, Finkelstein D, Ryan PD, Goss PE. Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy. Br J Cancer. 2014 Nov 25; 111(11):2046-50. PMID: 25233398.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  32. Chavarri-Guerra Y, St Louis J, Liedke PE, Symecko H, Villarreal-Garza C, Mohar A, Finkelstein DM, Goss PE. Access to care issues adversely affect breast cancer patients in Mexico: oncologists' perspective. BMC Cancer. 2014 Sep 09; 14:658. PMID: 25199766.
    Citations: 2     Fields:    Translation:Humans
  33. Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM, Goss PE. Breast cancer in China. Lancet Oncol. 2014 Jun; 15(7):e279-89. PMID: 24872111.
    Citations: 537     Fields:    Translation:Humans
  34. Dwojak SM, Finkelstein DM, Emerick KS, Lee JH, Petereit DG, Deschler DG. Poor Survival for American Indians with Head and Neck Squamous Cell Carcinoma. Otolaryngol Head Neck Surg. 2014 08; 151(2):265-71. PMID: 24781656.
    Citations: 5     Fields:    Translation:Humans
  35. Hill DA, Horick NK, Isaacs C, Domchek SM, Tomlinson GE, Lowery JT, Kinney AY, Berg JS, Edwards KL, Moorman PG, Plon SE, Strong LC, Ziogas A, Griffin CA, Kasten CH, Finkelstein DM. Long-term risk of medical conditions associated with breast cancer treatment. Breast Cancer Res Treat. 2014 May; 145(1):233-43. PMID: 24696430.
    Citations: 8     Fields:    Translation:Humans
  36. Schaid DJ, Spraggs CF, McDonnell SK, Parham LR, Cox CJ, Ejlertsen B, Finkelstein DM, Rappold E, Curran J, Cardon LR, Goss PE. Prospective validation of HLA-DRB1*07:01 allele carriage as a predictive risk factor for lapatinib-induced liver injury. J Clin Oncol. 2014 Aug 01; 32(22):2296-303. PMID: 24687830.
    Citations: 29     Fields:    Translation:Humans
  37. Finkelstein DM, Schoenfeld DA. A joint test for progression and survival with interval-censored data from a cancer clinical trial. Stat Med. 2014 May 30; 33(12):1981-9. PMID: 24500790.
    Citations: 2     Fields:    Translation:Humans
  38. Lowery JT, Horick N, Kinney AY, Finkelstein DM, Garrett K, Haile RW, Lindor NM, Newcomb PA, Sandler RS, Burke C, Hill DA, Ahnen DJ. A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network. Cancer Epidemiol Biomarkers Prev. 2014 Apr; 23(4):601-10. PMID: 24501379.
    Citations: 28     Fields:    Translation:HumansPHPublic Health
  39. Liedke PE, Finkelstein DM, Szymonifka J, Barrios CH, Chavarri-Guerra Y, Bines J, Vasconcelos C, Simon SD, Goss PE. Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort study. Cancer Epidemiol Biomarkers Prev. 2014 Jan; 23(1):126-33. PMID: 24165578.
    Citations: 23     Fields:    Translation:Humans
  40. Specht MC, Miller CL, Russell TA, Horick N, Skolny MN, O'Toole JA, Jammallo LS, Niemierko A, Sadek BT, Shenouda MN, Finkelstein DM, Smith BL, Taghian AG. Defining a threshold for intervention in breast cancer-related lymphedema: what level of arm volume increase predicts progression? Breast Cancer Res Treat. 2013 Aug; 140(3):485-94. PMID: 23912961.
    Citations: 30     Fields:    Translation:HumansCTClinical Trials
  41. Sgroi DC, Carney E, Zarrella E, Steffel L, Binns SN, Finkelstein DM, Szymonifka J, Bhan AK, Shepherd LE, Zhang Y, Schnabel CA, Erlander MG, Ingle JN, Porter P, Muss HB, Pritchard KI, Tu D, Rimm DL, Goss PE. Prediction of late disease recurrence and extended adjuvant letrozole benefit by the HOXB13/IL17BR biomarker. J Natl Cancer Inst. 2013 Jul 17; 105(14):1036-42. PMID: 23812955.
    Citations: 65     Fields:    Translation:Humans
  42. Welty LJ, Carter RE, Finkelstein DM, Harrell FE, Lindsell CJ, Macaluso M, Mazumdar M, Nietert PJ, Oster RA, Pollock BH, Roberson PK, Ware JH. Strategies for developing biostatistics resources in an academic health center. Acad Med. 2013 Apr; 88(4):454-60. PMID: 23425984; PMCID: PMC3610776.
    Citations: 18     Fields:    Translation:Humans
  43. Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, St Louis J, Villarreal-Garza C, Unger-Saldaña K, Ferreyra M, Debiasi M, Liedke PE, Touya D, Werutsky G, Higgins M, Fan L, Vasconcelos C, Cazap E, Vallejos C, Mohar A, Knaul F, Arreola H, Batura R, Luciani S, Sullivan R, Finkelstein D, Simon S, Barrios C, Kightlinger R, Gelrud A, Bychkovsky V, Lopes G, Stefani S, Blaya M, Souza FH, Santos FS, Kaemmerer A, de Azambuja E, Zorilla AF, Murillo R, Jeronimo J, Tsu V, Carvalho A, Gil CF, Sternberg C, Dueñas-Gonzalez A, Sgroi D, Cuello M, Fresco R, Reis RM, Masera G, Gabús R, Ribeiro R, Knust R, Ismael G, Rosenblatt E, Roth B, Villa L, Solares AL, Leon MX, Torres-Vigil I, Covarrubias-Gomez A, Hernández A, Bertolino M, Schwartsmann G, Santillana S, Esteva F, Fein L, Mano M, Gomez H, Hurlbert M, Durstine A, Azenha G. Planning cancer control in Latin America and the Caribbean. Lancet Oncol. 2013 Apr; 14(5):391-436. PMID: 23628188.
    Citations: 152     Fields:    Translation:Humans
  44. Goss PE, Smith IE, O'Shaughnessy J, Ejlertsen B, Kaufmann M, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Chavarri-Guerra Y, Aktan G, Rappold E, Williams LS, Finkelstein DM. Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial. Lancet Oncol. 2013 Jan; 14(1):88-96. PMID: 23234763.
    Citations: 44     Fields:    Translation:HumansCTClinical Trials
  45. Chávarri-Guerra Y, Villarreal-Garza C, Liedke PE, Knaul F, Mohar A, Finkelstein DM, Goss PE. Breast cancer in Mexico: a growing challenge to health and the health system. Lancet Oncol. 2012 Aug; 13(8):e335-43. PMID: 22846838.
    Citations: 44     Fields:    Translation:HumansPHPublic Health
  46. Nehra D, Oyarvide VM, Mino-Kenudson M, Thayer SP, Ferrone CR, Wargo JA, Muzikansky A, Finkelstein D, Warshaw AL, Castillo CF. Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter? Pancreatology. 2012 Jul-Aug; 12(4):358-63. PMID: 22898638.
    Citations: 9     Fields:    Translation:Humans
  47. Lee BL, Liedke PE, Barrios CH, Simon SD, Finkelstein DM, Goss PE. Breast cancer in Brazil: present status and future goals. Lancet Oncol. 2012 Mar; 13(3):e95-e102. PMID: 22381937.
    Citations: 54     Fields:    Translation:HumansPHPublic Health
  48. Lowery JT, Marcus A, Kinney A, Bowen D, Finkelstein DM, Horick N, Garrett K, Haile R, Sandler R, Ahnen DJ. The Family Health Promotion Project (FHPP): design and baseline data from a randomized trial to increase colonoscopy screening in high risk families. Contemp Clin Trials. 2012 Mar; 33(2):426-35. PMID: 22101228.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  49. Morse RE, Nadkarni P, Schoenfeld DA, Finkelstein DM. Web-browser encryption of personal health information. BMC Med Inform Decis Mak. 2011 Nov 10; 11:70. PMID: 22073940.
    Citations: 2     Fields:    Translation:Humans
  50. Sgroi D, Carney E, Richardson E, Steffel L, Binns SN, Finkelstein DM, Shepherd LE, Kesty NC, Schnabel C, Erlander MG, Ingle JN, Porter P, Paik S, Muss HB, Pritchard KI, Tu D, Goss PE. Prediction of late recurrences by breast cancer index in the NCIC CTG MA.17 cohort. J Clin Oncol. 2011 Sep 20; 29(27_suppl):2. PMID: 27958176.
  51. Carp SA, Wanyo C, Specht MC, Schapira L, Moy B, Finkelstein DM, Boas D, Isakoff SJ. Functional metabolic tomographic optical breast imaging (TOBI) to monitor response to neoadjuvant therapy in breast cancer. J Clin Oncol. 2011 Sep 20; 29(27_suppl):60. PMID: 27958134.
  52. Skates SJ, Mai P, Horick NK, Piedmonte M, Drescher CW, Isaacs C, Armstrong DK, Buys SS, Rodriguez GC, Horowitz IR, Berchuck A, Daly MB, Domchek S, Cohn DE, Van Le L, Schorge JO, Newland W, Davidson SA, Barnes M, Brewster W, Azodi M, Nerenstone S, Kauff ND, Fabian CJ, Sluss PM, Nayfield SG, Kasten CH, Finkelstein DM, Greene MH, Lu K. Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal status. Cancer Prev Res (Phila). 2011 Sep; 4(9):1401-8. PMID: 21893500; PMCID: PMC3172691.
    Citations: 25     Fields:    Translation:Humans
  53. Ziogas A, Horick NK, Kinney AY, Lowery JT, Domchek SM, Isaacs C, Griffin CA, Moorman PG, Edwards KL, Hill DA, Berg JS, Tomlinson GE, Anton-Culver H, Strong LC, Kasten CH, Finkelstein DM, Plon SE. Clinically relevant changes in family history of cancer over time. JAMA. 2011 Jul 13; 306(2):172-8. PMID: 21750294; PMCID: PMC3367662.
    Citations: 26     Fields:    Translation:Humans
  54. Isakoff SJ, Goss PE, Mayer EL, Traina TA, Carey LA, Krag K, Rugo HS, Liu MC, Stearns V, Come SE, Borger DR, Quadrino CA, Finkelstein D, Garber JE, Ryan PD, Winer EP, Ellisen LW. TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple-negative breast cancer and evaluation of p63/p73 as a biomarker of response. J Clin Oncol. 2011 May 20; 29(15_suppl):1025. PMID: 28020734.
  55. Goss PE, Barrios CH, Bell R, Finkelstein D, Iwata H, Martin M, Braun AH, Dansey RD, Coleman RE. A randomized, double-blind, placebo-controlled multicenter phase III study comparing denosumab with placebo as adjuvant treatment for women with early-stage breast cancer who are at high risk of disease recurrence (D-CARE). J Clin Oncol. 2011 May 20; 29(15_suppl):TPS152. PMID: 28022982.
  56. Goss PE, Barrios CH, Chan A, Chia SK, Delaloge S, Ejlertsen B, Ingle JN, Moy B, Iwata H, Holmes FA, Mansi J, Von Minckwitz G, Han L, Thiele A, Agrapart V, Freyman A, Truscello J, Berkenblit A, Finkelstein D. A phase III trial of adjuvant neratinib (NER) after trastuzumab (TRAS) in women with early-stage HER2+ breast cancer (BC). J Clin Oncol. 2011 May 20; 29(15_suppl):TPS137. PMID: 28022891.
  57. Carp SA, Wanyo C, Specht M, Schapira L, Moy B, Finkelstein D, Boas D, Isakoff SJ. Functional metabolic tomographic optical breast imaging (TOBI) to monitor response to neoadjuvant therapy in breast cancer. J Clin Oncol. 2011 May 20; 29(15_suppl):10607. PMID: 28022835.
  58. Cigler T, Higgins MJ, Szymonifka J, Partridge AH, Ligibel JA, Finkelstein D, Come SE, Ryan PD, Goss PE. A phase II clinical trial of drug withdrawal in women with progressive breast cancer while on aromatase inhibitor therapy. J Clin Oncol. 2011 May 20; 29(15_suppl):559. PMID: 28021407.
  59. Finkelstein DM, Schoenfeld DA. Correcting for discretionary treatment crossover in an analysis of survival in the Breast International Group BIG 1-98 trial by using the inverse probability of censoring weighted method. J Clin Oncol. 2011 Mar 20; 29(9):1093-5. PMID: 21321297.
    Citations: 7     Fields:    Translation:Humans
  60. Schoenfeld DA, Rajicic N, Ficociello LH, Finkelstein DM. A test for the relationship between a time-varying marker and both recovery and progression with missing data. Stat Med. 2011 Mar 30; 30(7):718-24. PMID: 21394748.
    Citations: 1     Fields:    Translation:Humans
  61. Rajicic N, Cuschieri J, Finkelstein DM, Miller-Graziano CL, Hayden D, Moldawer LL, Moore E, O'Keefe G, Pelik K, Warren HS, Schoenfeld DA. Identification and interpretation of longitudinal gene expression changes in trauma. PLoS One. 2010 Dec 20; 5(12):e14380. PMID: 21187951.
    Citations: 8     Fields:    Translation:HumansCells
  62. Rizvi I, Celli JP, Evans CL, Abu-Yousif AO, Muzikansky A, Pogue BW, Finkelstein D, Hasan T. Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer. Cancer Res. 2010 Nov 15; 70(22):9319-28. PMID: 21062986.
    Citations: 83     Fields:    Translation:HumansCells
  63. Finkelstein DM, Wang R, Ficociello LH, Schoenfeld DA. A score test for association of a longitudinal marker and an event with missing data. Biometrics. 2010 Sep; 66(3):726-32. PMID: 19754923.
    Citations: 2     Fields:    Translation:Humans
  64. Moorman PG, Iversen ES, Marcom PK, Marks JR, Wang F, Lee E, Ursin G, Rebbeck TR, Domchek SM, Arun B, Susswein L, Isaacs C, Garber JE, Visvanathan K, Griffin CA, Sutphen R, Brzosowicz J, Gruber S, Finkelstein DM, Schildkraut JM. Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis. Breast Cancer Res Treat. 2010 Nov; 124(2):441-51. PMID: 20309627.
    Citations: 15     Fields:    Translation:Humans
  65. Nichols AC, Finkelstein DM, Faquin WC, Westra WH, Mroz EA, Kneuertz P, Begum S, Michaud WA, Busse PM, Clark JR, Rocco JW. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer. Clin Cancer Res. 2010 Apr 01; 16(7):2138-46. PMID: 20233885.
    Citations: 22     Fields:    Translation:HumansCells
  66. Crippa S, Fernández-Del Castillo C, Salvia R, Finkelstein D, Bassi C, Domínguez I, Muzikansky A, Thayer SP, Falconi M, Mino-Kenudson M, Capelli P, Lauwers GY, Partelli S, Pederzoli P, Warshaw AL. Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. Clin Gastroenterol Hepatol. 2010 Feb; 8(2):213-9. PMID: 19835989.
    Citations: 103     Fields:    Translation:Humans
  67. Rajicic N, Finkelstein DM, Schoenfeld DA. Analysis of the relationship between longitudinal gene expressions and ordered categorical event data. Stat Med. 2009 Sep 30; 28(22):2817-32. PMID: 19618375.
    Citations: 2     Fields:    Translation:Humans
  68. Schoenfeld DA, Finkelstein DM. Bayesian design using adult data to augment pediatric trials. Clin Trials. 2009 Aug; 6(4):297-304. PMID: 19667026.
    Citations: 18     Fields:    Translation:Humans
  69. Souglakos J, Philips J, Wang R, Marwah S, Silver M, Tzardi M, Silver J, Ogino S, Hooshmand S, Kwak E, Freed E, Meyerhardt JA, Saridaki Z, Georgoulias V, Finkelstein D, Fuchs CS, Kulke MH, Shivdasani RA. Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer. Br J Cancer. 2009 Aug 04; 101(3):465-72. PMID: 19603024.
    Citations: 132     Fields:    Translation:Humans
  70. Neklason DW, Kerber RA, Nilson DB, Anton-Culver H, Schwartz AG, Griffin CA, Lowery JT, Schildkraut JM, Evans JP, Tomlinson GE, Strong LC, Miller AR, Stopfer JE, Finkelstein DM, Nadkarni PM, Kasten CH, Mineau GP, Burt RW. Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis. Cancer Res. 2008 Nov 01; 68(21):8993-7. PMID: 18974144; PMCID: PMC2927856.
    Citations: 22     Fields:    Translation:HumansCells
  71. Matthews AG, Finkelstein DM, Betensky RA. Analysis of familial aggregation studies with complex ascertainment schemes. Stat Med. 2008 Oct 30; 27(24):5076-92. PMID: 18618413.
    Citations: 10     Fields:    Translation:Humans
  72. Kerber RA, Amos CI, Yeap BY, Finkelstein DM, Thomas DC. Design considerations in a sib-pair study of linkage for susceptibility loci in cancer. BMC Med Genet. 2008 Jul 10; 9:64. PMID: 18616822.
    Citations: 1     Fields:    Translation:Humans
  73. Bell DW, Brannigan BW, Matsuo K, Finkelstein DM, Sordella R, Settleman J, Mitsudomi T, Haber DA. Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms. Clin Cancer Res. 2008 Jul 01; 14(13):4079-84. PMID: 18593984.
    Citations: 26     Fields:    Translation:Humans
  74. Alm El-Din MA, Hughes KS, Finkelstein DM, Betts KA, Yock TI, Tarbell NJ, Aisenberg AC, Taghian AG. Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter. Int J Radiat Oncol Biol Phys. 2009 Jan 01; 73(1):69-74. PMID: 18538497.
    Citations: 11     Fields:    Translation:Humans
  75. Tanabe KK, Lemoine A, Finkelstein DM, Kawasaki H, Fujii T, Chung RT, Lauwers GY, Kulu Y, Muzikansky A, Kuruppu D, Lanuti M, Goodwin JM, Azoulay D, Fuchs BC. Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis. JAMA. 2008 Jan 02; 299(1):53-60. PMID: 18167406.
    Citations: 89     Fields:    Translation:HumansCells
  76. Parmigiani G, Chen S, Iversen ES, Friebel TM, Finkelstein DM, Anton-Culver H, Ziogas A, Weber BL, Eisen A, Malone KE, Daling JR, Hsu L, Ostrander EA, Peterson LE, Schildkraut JM, Isaacs C, Corio C, Leondaridis L, Tomlinson G, Amos CI, Strong LC, Berry DA, Weitzel JN, Sand S, Dutson D, Kerber R, Peshkin BN, Euhus DM. Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med. 2007 Oct 02; 147(7):441-50. PMID: 17909205; PMCID: PMC2423214.
    Citations: 38     Fields:    Translation:Humans
  77. Zhang Z, Sun L, Sun J, Finkelstein DM. Regression analysis of failure time data with informative interval censoring. Stat Med. 2007 May 30; 26(12):2533-46. PMID: 17072823.
    Citations: 4     Fields:    Translation:HumansAnimals
  78. Matthews AG, Finkelstein DM, Betensky RA. Multivariate logistic regression for familial aggregation in age at disease onset. Lifetime Data Anal. 2007 Jun; 13(2):191-209. PMID: 17410428.
    Citations: 2     Fields:    Translation:Humans
  79. Stephen AE, Roth SI, Fardo DW, Finkelstein DM, Randolph GW, Gaz RD, Hodin RA. Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas. Arch Surg. 2007 Apr; 142(4):381-6. PMID: 17441292.
    Citations: 13     Fields:    Translation:Humans
  80. Ficociello LH, Perkins BA, Silva KH, Finkelstein DM, Ignatowska-Switalska H, Gaciong Z, Cupples LA, Aschengrau A, Warram JH, Krolewski AS. Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors. Clin J Am Soc Nephrol. 2007 May; 2(3):461-9. PMID: 17699452.
    Citations: 24     Fields:    Translation:Humans
  81. Rajicic N, Finkelstein DM, Schoenfeld DA. Survival analysis of longitudinal microarrays. Bioinformatics. 2006 Nov 01; 22(21):2643-9. PMID: 17032680.
    Citations: 6     Fields:    
  82. Finkelstein D, Lamba V, Assem M, Rengelshausen J, Yasuda K, Strom S, Schuetz E. ADME transcriptome in Hispanic versus White donor livers: evidence of a globally enhanced NR1I3 (CAR, constitutive androstane receptor) gene signature in Hispanics. Xenobiotica. 2006 Oct-Nov; 36(10-11):989-1012. PMID: 17118917.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  83. Ferrone CR, Finkelstein DM, Thayer SP, Muzikansky A, Fernandez-delCastillo C, Warshaw AL. Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma. J Clin Oncol. 2006 Jun 20; 24(18):2897-902. PMID: 16782929; PMCID: PMC3817569.
    Citations: 180     Fields:    Translation:Humans
  84. Chen S, Iversen ES, Friebel T, Finkelstein D, Weber BL, Eisen A, Peterson LE, Schildkraut JM, Isaacs C, Peshkin BN, Corio C, Leondaridis L, Tomlinson G, Dutson D, Kerber R, Amos CI, Strong LC, Berry DA, Euhus DM, Parmigiani G. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. J Clin Oncol. 2006 Feb 20; 24(6):863-71. PMID: 16484695; PMCID: PMC2323978.
    Citations: 119     Fields:    Translation:Humans
  85. Matthews AG, Betensky RA, Anton-Culver H, Bowen D, Griffin C, Isaacs C, Kasten C, Mineau G, Nayfield S, Schildkraut J, Strong L, Weber B, Finkelstein DM. Analysis of co-aggregation of cancer based on registry data. Community Genet. 2006; 9(2):87-92. PMID: 16612058.
    Citations: 2     Fields:    Translation:Humans
  86. Amrein PC, Clark JR, Supko JG, Fabian RL, Wang CC, Colevas AD, Posner MR, Deschler DG, Rocco JW, Finkelstein DM, McIntyre JF. Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinoma. Cancer. 2005 Oct 01; 104(7):1418-27. PMID: 16116597.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  87. Tyminski E, Leroy S, Terada K, Finkelstein DM, Hyatt JL, Danks MK, Potter PM, Saeki Y, Chiocca EA. Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecan. Cancer Res. 2005 Aug 01; 65(15):6850-7. PMID: 16061668.
    Citations: 48     Fields:    Translation:HumansCells
  88. Ferrone CR, Thayer SP, Finkelstein DM, Muzikansky A, Mino-Kenudson M, Lauwers G, Warshaw AL. A decrease in preoperative to postoperative CA19-9 level is a significant predictor of survival in patients with pancreatic adenocarcinoma. J Clin Oncol. 2005 Jun; 23(16_suppl):4034. PMID: 27944136.
  89. Nguyen PL, Chakravarti A, Finkelstein DM, Hochberg FH, Batchelor TT, Loeffler JS. Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma. J Clin Oncol. 2005 Mar 01; 23(7):1507-13. PMID: 15735126.
    Citations: 53     Fields:    Translation:Humans
  90. Ancukiewicz M, Finkelstein DM, Schoenfeld DA. Modelling the relationship between continuous covariates and clinical events using isotonic regression. Stat Med. 2003 Oct 30; 22(20):3151-9. PMID: 14518020.
    Citations: 3     Fields:    Translation:Humans
  91. Finkelstein DM, Muzikansky A, Schoenfeld DA. Comparing survival of a sample to that of a standard population. J Natl Cancer Inst. 2003 Oct 01; 95(19):1434-9. PMID: 14519749.
    Citations: 30     Fields:    Translation:Humans
  92. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. N Engl J Med. 2003 Jun 05; 348(23):2285-93. PMID: 12788992.
    Citations: 258     Fields:    Translation:Humans
  93. Pierie JP, Choudry U, Muzikansky A, Finkelstein DM, Ott MJ. Prognosis and management of extramammary Paget's disease and the association with secondary malignancies. J Am Coll Surg. 2003 Jan; 196(1):45-50. PMID: 12517548.
    Citations: 19     Fields:    Translation:Humans
  94. Anton-Culver H, Ziogas A, Bowen D, Finkelstein D, Griffin C, Hanson J, Isaacs C, Kasten-Sportes C, Mineau G, Nadkarni P, Rimer B, Schildkraut J, Strong L, Weber B, Winn D, Hiatt R, Nayfield S. The Cancer Genetics Network: recruitment results and pilot studies. Community Genet. 2003; 6(3):171-7. PMID: 15237201.
    Citations: 30     Fields:    Translation:Humans
  95. Pauler DK, Finkelstein DM. Predicting time to prostate cancer recurrence based on joint models for non-linear longitudinal biomarkers and event time outcomes. Stat Med. 2002 Dec 30; 21(24):3897-911. PMID: 12483774.
    Citations: 17     Fields:    Translation:Humans
  96. Ettinger DS, Finkelstein DM, Ritch PS, Lincoln ST, Blum RH. Study of either ifosfamide or teniposide compared to a standard chemotherapy for extensive disease small cell lung cancer: an Eastern Cooperative Oncology Group randomized study (E1588). Lung Cancer. 2002 Sep; 37(3):311-8. PMID: 12234701.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  97. Hodi FS, Soiffer RJ, Clark J, Finkelstein DM, Haluska FG. Phase II study of paclitaxel and carboplatin for malignant melanoma. Am J Clin Oncol. 2002 Jun; 25(3):283-6. PMID: 12040289.
    Citations: 22     Fields:    Translation:HumansCTClinical Trials
  98. Finkelstein DM, Goggins WB, Schoenfeld DA. Analysis of failure time data with dependent interval censoring. Biometrics. 2002 Jun; 58(2):298-304. PMID: 12071402.
    Citations: 7     Fields:    Translation:HumansCells
  99. Betensky RA, Finkelstein DM. Testing for dependence between failure time and visit compliance with interval-censored data. Biometrics. 2002 Mar; 58(1):58-63. PMID: 11890327.
    Citations: 2     Fields:    Translation:HumansCells
  100. Chakravarti A, Noll E, Black PM, Finkelstein DF, Finkelstein DM, Dyson NJ, Loeffler JS. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J Clin Oncol. 2002 Feb 15; 20(4):1063-8. PMID: 11844831.
    Citations: 95     Fields:    Translation:Humans
  101. DiRienzo AG, van Der Horst C, Finkelstein DM, Frame P, Bozzette SA, Tashima KT. Efficacy of trimethoprim-sulfamethoxazole for the prevention of bacterial infections in a randomized prophylaxis trial of patients with advanced HIV infection. AIDS Res Hum Retroviruses. 2002 Jan 20; 18(2):89-94. PMID: 11839141.
    Citations: 7     Fields:    Translation:HumansCTClinical Trials
  102. Shannon KM, Lubratovich ML, Finkelstein DM, Smith BL, Powell SN, Seiden MV. Model-based predictions of BRCA1/2 mutation status in breast carcinoma patients treated at an academic medical center. Cancer. 2002 Jan 15; 94(2):305-13. PMID: 11900216.
    Citations: 7     Fields:    Translation:Humans
  103. McKee GT, Tambouret RH, Finkelstein D. A reliable method of demonstrating HER-2/neu, estrogen receptors, and progesterone receptors on routinely processed cytologic material. Appl Immunohistochem Mol Morphol. 2001 Dec; 9(4):352-7. PMID: 11759063.
    Citations: 2     Fields:    Translation:Humans
  104. McKee GT, Tambouret RH, Finkelstein D. Fine-needle aspiration cytology of the breast: Invasive vs. in situ carcinoma. Diagn Cytopathol. 2001 Jul; 25(1):73-7. PMID: 11466818.
    Citations: 3     Fields:    Translation:Humans
  105. Pai HH, Thornton A, Katznelson L, Finkelstein DM, Adams JA, Fullerton BC, Loeffler JS, Leibsch NJ, Klibanski A, Munzenrider JE. Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2001 Mar 15; 49(4):1079-92. PMID: 11240250.
    Citations: 25     Fields:    Translation:Humans
  106. Goggins WB, Finkelstein DM, Tsao H. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer. 2001 Feb 15; 91(4):874-80. PMID: 11241258.
    Citations: 14     Fields:    Translation:Humans
  107. Breathnach OS, Kwiatkowski DJ, Finkelstein DM, Godleski J, Sugarbaker DJ, Johnson BE, Mentzer S. Bronchioloalveolar carcinoma of the lung: recurrences and survival in patients with stage I disease. J Thorac Cardiovasc Surg. 2001 Jan; 121(1):42-7. PMID: 11135158.
    Citations: 14     Fields:    Translation:Humans
  108. Wenkel E, Thornton AF, Finkelstein D, Adams J, Lyons S, De La Monte S, Ojeman RG, Munzenrider JE. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys. 2000 Dec 01; 48(5):1363-70. PMID: 11121635.
    Citations: 27     Fields:    Translation:HumansPHPublic Health
  109. Chaudhuri S, Cariappa A, Tang M, Bell D, Haber DA, Isselbacher KJ, Finkelstein D, Forcione D, Pillai S. Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles. Proc Natl Acad Sci U S A. 2000 Oct 10; 97(21):11451-4. PMID: 11027344; PMCID: PMC17220.
    Citations: 27     Fields:    Translation:Humans
  110. Robins JM, Finkelstein DM. Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics. 2000 Sep; 56(3):779-88. PMID: 10985216.
    Citations: 233     Fields:    Translation:HumansCTClinical Trials
  111. Tsao H, Zhang X, Kwitkiwski K, Finkelstein DM, Sober AJ, Haluska FG. Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma. Arch Dermatol. 2000 Sep; 136(9):1118-22. PMID: 10987867.
    Citations: 19     Fields:    Translation:Humans
  112. Goggins WB, Finkelstein DM. A proportional hazards model for multivariate interval-censored failure time data. Biometrics. 2000 Sep; 56(3):940-3. PMID: 10985240.
    Citations: 19     Fields:    Translation:HumansCells
  113. Para MF, Finkelstein D, Becker S, Dohn M, Walawander A, Black JR. Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268. J Acquir Immune Defic Syndr. 2000 Aug 01; 24(4):337-43. PMID: 11015150.
    Citations: 9     Fields:    Translation:HumansCellsCTClinical Trials
  114. Domchek SM, Younger J, Finkelstein DM, Seiden MV. Predictors of skeletal complications in patients with metastatic breast carcinoma. Cancer. 2000 Jul 15; 89(2):363-8. PMID: 10918167.
    Citations: 43     Fields:    Translation:HumansPHPublic Health
  115. Harsh GR, Deisboeck TS, Louis DN, Hilton J, Colvin M, Silver JS, Qureshi NH, Kracher J, Finkelstein D, Chiocca EA, Hochberg FH. Thymidine kinase activation of ganciclovir in recurrent malignant gliomas: a gene-marking and neuropathological study. J Neurosurg. 2000 May; 92(5):804-11. PMID: 10794295.
    Citations: 27     Fields:    Translation:HumansAnimalsCells
  116. Chakravatri A, Zehr EM, Zietman AL, Shipley WU, Goggins WB, Finkelstein DM, Young RH, Chang EL, Wu CL. Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer-results from a pilot study. Urology. 2000 May; 55(5):635-8. PMID: 10792068.
    Citations: 5     Fields:    Translation:Humans
  117. Aisenberg AC, Finkelstein DM. Second malignancies in Hodgkin's disease. J Clin Oncol. 2000 May; 18(10):2186-7. PMID: 10811685.
    Citations: 1     Fields:    Translation:Humans
  118. Wolfe BE, Metzger ED, Levine JM, Finkelstein DM, Cooper TB, Jimerson DC. Serotonin function following remission from bulimia nervosa. Neuropsychopharmacology. 2000 Mar; 22(3):257-63. PMID: 10693153.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  119. Myojin M, Choi NC, Wright CD, Wain JC, Harris N, Hug EB, Mathisen DJ, Lynch T, Carey RW, Grossbard M, Finkelstein DM, Grillo HC. Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. Int J Radiat Oncol Biol Phys. 2000 Mar 01; 46(4):927-33. PMID: 10705015.
    Citations: 20     Fields:    Translation:Humans
  120. Ryan DP, Lynch TJ, Grossbard ML, Seiden MV, Fuchs CS, Grenon N, Baccala P, Berg D, Finkelstein D, Mayer RJ, Clark JW. A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors. Cancer. 2000 Jan 01; 88(1):180-5. PMID: 10618622.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  121. Dubovy SR, Hairston RJ, Schatz H, Schachat AP, Bressler NM, Finkelstein D, Green WR. Adult-onset foveomacular pigment epithelial dystrophy: clinicopathologic correlation of three cases. Retina. 2000; 20(6):638-49. PMID: 11131418.
    Citations: 11     Fields:    Translation:HumansCells
  122. Betensky RA, Finkelstein DM. An extension of Kendall's coefficient of concordance to bivariate interval censored data. Stat Med. 1999 Nov 30; 18(22):3101-9. PMID: 10544309.
    Citations: 1     Fields:    Translation:HumansCells
  123. Betensky RA, Finkelstein DM. A non-parametric maximum likelihood estimator for bivariate interval censored data. Stat Med. 1999 Nov 30; 18(22):3089-100. PMID: 10544308.
    Citations: 10     Fields:    Translation:HumansCells
  124. Goggins WB, Finkelstein DM, Zaslavsky AM. Applying the Cox proportional hazards model for analysis of latency data with interval censoring. Stat Med. 1999 Oct 30; 18(20):2737-47. PMID: 10521863.
    Citations: 6